Uxin Limited

Ladies and gentlemen, thank you for standing by and welcome to Eugene's earnings conference call for the quarter ended December 31st, 2022. This time, all participants are in a listen-only mode. After management's prepared remarks, there will be a Q&A session. Today's conference call is being recorded. If you have any questions, you may disconnect at this time. I would now like to turn the call over to your host for today's conference call, Mr. Jack Wong. Please go ahead, Jack.

Thank you, operator. Hello, everyone. Welcome to UCI's earnings conference call. Fourth quarter ended December 31st, 2022. On the call with me today, we have CK, our founder and CEO, and John Lin, our CFO. CK will review business operations and company highlights, followed by John, who will discuss our financials and guidance. They will both be available to answer questions during the Q&A session that follows. Before we proceed, I would like to remind you that this call may contain forward-looking statements, which are inherently subject to risks and uncertainties that may cause actual results to differ from our current expectations. For detailed discussions of the risks and uncertainties, please refer to our filings with the SEC. Now, with that, I will turn the call over to our CEO. CK, please go ahead, sir.

Thanks, Jack. Hello, everyone. Thank you for joining our earnings conference call today. To accommodate both domestic and international investors, I will provide an overview of our business progress in both English and Chinese. I will start today's call by reviewing the key focal points of our efforts this quarter and then share an update on the direction we're pursuing as well as the recent market trend. During the third quarter of fiscal year 2023, from October to December 2022, the stringent COVID control measures created huge impacts and fluctuations in the market. Despite such impacts, our retail sales volume for the quarter reached 2,928 units, representing an impressive 77% year-over-year growth.